Healthcare strategy THRIVE serves global healthcare and biopharma leaders, biotechs, and family office principals, indicating potential sales opportunities in late-stage pharma launches, disease area focus, and high-profile healthcare clients seeking launch excellence and futures architecture.

Launch expertise With a focus on launch strategy, readiness, and post-launch optimization, there is a clear opportunity to upsell continuous strategy support for product launches, lifecycle management, and portfolio optimization across multiple regions.

Repeat business Over 90% repeat/referral rate signals strong client satisfaction and potential for expanded engagements within existing accounts, including cross-sell into boards and family offices for strategic futures planning.

Global reach Active engagement across North America, Europe, and Asia-Pacific presents avenues to pursue multi-region launches, localization strategies, and compliance/adaptation services for diverse regulatory landscapes.

Financial signal Revenue in the range of one to ten million and a substantial impact metric of over $100B in cumulative sales from supported launches highlight THRIVE as a lean, credible partner for mid-market to upper-mid-market opportunities seeking high ROI.